Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：0
|
作者：
Omer Jamy
Kendall Diebold
Kenneth Davis
Kimo Bachiashvili
Sravanti Rangaraju
Pankit Vachhani
Kelly N. Godby
Donna Salzman
Ravi Bhatia
机构：
[1] University of Alabama at Birmingham,Division of Hematology and Oncology, Department of Medicine
[2] University of Alabama at Birmingham,School of Medicine
来源：
Bone Marrow Transplantation | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：823 / 825
页数：2
相关论文
共 50 条
  • [1] Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia
    Jamy, Omer
    Diebold, Kendall
    Davis, Kenneth
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Godby, Kelly N.
    Salzman, Donna
    Bhatia, Ravi
    BONE MARROW TRANSPLANTATION, 2023, 58 (07) : 823 - 825
  • [2] Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53-Mutated Acute Myeloid Leukemia
    Jamy, Omer H.
    Diebold, Kendall
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Godby, Kelly N.
    Salzman, Donna
    Bhatia, Ravi
    BLOOD, 2022, 140 : 8959 - 8960
  • [3] Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia
    Boddu, Prajwal
    Kantarjian, Hagop
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias J.
    Benton, Christopher B.
    DiNardo, Courtney D.
    Konopleva, Marina
    Daver, Naval
    Patel, Keyur
    Takahashi, Koichi
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge
    Kadia, Tapan
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2238 - 2241
  • [4] TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [5] Precision medicine for TP53-mutated acute myeloid leukemia
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (05): : 263 - 274
  • [6] Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
    Shallis, Rory M.
    Bewersdorf, Jan P.
    Stahl, Maximilian F.
    Halene, Stephanie
    Zeidan, Amer M.
    CANCERS, 2022, 14 (10)
  • [7] Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia
    Vanttinen, Ida
    Ruokoranta, Tanja
    Saad, Joseph J.
    Kytola, Sari
    Hellesoy, Monica
    Gullaksen, Stein-Erik
    Ettala, Pia-Sofia
    Pyorala, Marja
    Rimpilainen, Johanna
    Siitonen, Timo
    Wennerberg, Krister
    Gjertsen, Bjorn T.
    Heckman, Caroline A.
    Kontro, Mika
    Kuusanmaki, Heikki
    BLOOD, 2023, 142
  • [8] TP53-Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges
    Ghimire, Bipin
    Zimmer, Markie
    Donthireddy, Vijayalakshmi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [9] Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
    Granowicz, Eric M.
    Jonas, Brian A.
    ONCOTARGETS AND THERAPY, 2022, 15 : 423 - 436
  • [10] Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Wei, Wei
    Hager, Karl
    Isufi, Iris
    Kim, Tae Kon
    Pillai, Manoj M.
    Seropian, Stuart
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Siddon, Alexa J.
    Zeidan, Amer M.
    LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2180 - 2190
12345